Hypocholesterolemia is not associated with neurotoxicity in renal transplant patients

International Journal of Artificial Organs

Volumn 19, Issue 6, 1996, Pages 343-346

  Trivedi, H S ^a   Lal, S M ^a,c   Gupta, N ^a   Ross, G ^b  

^a Department of Internal Medicine ^*

^b University of Missouri   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Cyclosporine; Hypocholesteromia; Neurotoxicity; Renal transplant

Indexed keywords

PATIENT TREATMENT; CHOLESTEROL;

BONE MARROW TRANSPLANTATION; CYCLOSPORINE; HYPOCHOLESTEROMIA; INDUCTION THERAPY; LONG TERM OBSERVATIONS; NEUROTOXICITY; RENAL TRANSPLANT RECIPIENTS; RENAL TRANSPLANTATION; RENAL TRANSPLANTS; TOTAL CHOLESTEROLS;

CHOLESTEROL; PATIENT TREATMENT;

AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN; NICOTINIC ACID; PREDNISONE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HUMAN; HYPOCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; RECIPIENT;

EID: 0029682260     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. De Groen PC, Aksamit AJ, Rakela J, Forbes GS, Krom RAF. Central nervous toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med 1987; 317: 861-6
2. Heck CF, Shumway SJ, Kaye MP. Registry of the International Society for Heart Transplantation: sixth official report. J Heart Transplant 1989; 8: 271-6.
3. Wilzek H, Ringden O, Gunnar T. Cyclosporine-associated neurotoxicity after renal transplantation. Transplantation 1985; 39: 110.
4. Bergen JHM, Hoitsma AJ, Merx JL, Keyser A. Severe central nervous system toxicity associated with cyclosporine. Lancet 1985; 1: 219-20.
5. Atkinson K, Biggs J, Darveniza P, Boland J, Concannon A, Dodds A. Cyclosporine-associated central nervous system toxicity after allogenic bone marrow transplantation. Transplantation 1984: 38: 34-7.
6. Vazquez de Prada JA, Martin-Duran R, Garcia-Monco C, et al. Cyclosporine neurotoxicity in heart transplantation. J Heart Transplant 1990; 9: 581-3.
7. McManus RP, O'Hair DP, Schweiger J, Beitzinger J, Siegal R. Cyclosporine-associated neurotoxicity after heart transplantation. Ann Thorac Surg 1992: 53: 326-7.
8. De Groen PC. Cyclosporine, low-density lipoprotein, and cholesterol. Mayo Clin Proc 1988; 63: 1012-21.
9. Thompson CB, June CH, Sullivan KM, Thomas ED. Association between cyclosporine toxicity and hypomagnesemia. Lancet 1984; 2: 1116-20.
10. Sloane JP, Lwin KY, Gore ME, Powles RL, Smith JF. Disturbance of blood-brain barrier after bone-marrow transplantation (letter to the editor). Lancet 1985; 2: 280-1.
11. Neild GH, Rocchi G, Imberti L, Fumagalli F, Brown Z, Remuzzi G, Williams DG. Effect of cyclosporine A on prostacyclin synthesis by vascular tissue. Thromb Res 1983; 32: 373-9.
12. Brown Z, Meild GH. Cyclosporine inhibits prostacyclin production by cultured human endothelial cells. Transplant Proc 1987; 19: 1178-80.
13. 2 release from vascular smooth cells. Biochem Biophys Res Comm 1987; 147: 542-9.
14. Bjorkhem I. Mechanisms of bile acid biosynthesis mamma-lian liver. In: Danielsson H, Sjovall J, eds. New comprehensive biochemistry. Amsterdam. Elsevier Science Publishers BV 1985; 12: 231-78.
15. Koopman BJ, Wolthers BG, van der Molen JC, van der Slik W, Waterreus RJ, van Spreeken A. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in the Netherlands. J Inherited Metab Dis 1988; 11: 56-75.
16. Salen G, Shefer S, Berginer VM. Familial diseases with storage of sterols other than cholesterol: cerebrotendimatosis. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, et al eds. The metabolic basis of inherited disease. New York: McGraw Hill Book Company 1983; 713-30.
17. Oftebro H, Bjorkhem I, Skrede S, Schreiner A, Pedersen JI. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid. J Clin Invest 1980; 65: 1418-30.
18. Princen HMG, Meijer P, Hofstee B, Havekes LM, Kuipers F, Vonk RJ. Effects of cyclosporin A (CsA) on LDL receptor activity and bile acid synthesis in hepatocyte monolayer cultures and in vivo in rat (abstract). Hepatology 1987; 7: 1109.